Management attributed part of the weakness to one-time items tied to a strategic pivot away from compounded weight-loss drugs, including approximately $33.5 million in restructuring charges. ・The ...
SureNano Science is advancing GEP-44 as a next-generation metabolic therapy intended to improve upon limitations associated with first-generation GLP-1 drugs. The global GLP-1 market could total more ...
The unchanged US$9.88 fair value estimate for LifeMD keeps the core price target steady, even as model inputs see only marginal tweaks. That stability lines up with recent analyst debate around Q4 ...
Common GLP-1s include semaglutides like Ozempic and Wegovy, and tirzepatides like Zepbound and Mounjaro. These drugs work by mimicking a natural hormone to regulate appetite, blood sugar, and feelings ...
Denver, Colorado--(Newsfile Corp. - April 23, 2026) - Core Progression Elite Personal Training ("Core Progression") and Vitelize Health ("Vitelize") have launched a coordinated GLP-1 weight-loss model ...
A GLP-1 Bridge pilot program launching in July can significantly reduce the price you pay for weight loss meds. Here’s how to ...
GLP-1 drugs such as Ozempic and Mounjaro are a revolution, not a trend. These weight loss drugs are one of the hottest markets in healthcare, and there’s been a dramatic surge in the number of ...
GLP-1 medications can alter bowel movements, with constipation and diarrhea being the most common side effects. These drugs slow digestion to help control appetite, which can lead to changes in stool ...
Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular ...
Under the Bridge program, eligible beneficiaries can get Medicare coverage of GLP-1s for obesity for a $50 copay. Extending the short-term GLP-1 Bridge program is good news for eligible Medicare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results